Backblaze Investor News: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Backblaze securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=38633 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On April 24, 2024, during market hours, Investing.com issued an article entitled, 'Backblaze stock plunges amid Morpheus Research report.' This article stated that Backblaze 'saw its shares plummet' as a result of a 'scathing short report from Morpheus Research. The report detailed a series of alleged financial missteps and questionable practices since the company's initial public offering (IPO) in November 2021.' The article further noted that Morpheus's report 'highlights questionable accounting practices, including financial manipulations and inflated forecasts to pass audit thresholds.'
On this news, Backblaze stock fell 2.1% on April 24, 2025.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
——————————-
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Upcoming Stock Splits This Week (June 16 to June 20)
These are the upcoming stock splits for the week of June 16 to June 20, based on TipRanks' Stock Splits Calendar. A stock split occurs when a company issues additional shares to existing investors, increasing the total share count without changing its overall market value. The result is a lower price per share, making the stock appear more affordable to everyday investors. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter On the flip side, a reverse stock split shrinks the share count by combining existing shares, driving the price per share higher while keeping the total valuation intact. Companies often use this move to stay in compliance with stock exchange rules, particularly when their share price is hovering near delisting thresholds like Nasdaq's minimum requirement. Whether to attract investor attention or to meet listing standards, these maneuvers can offer important clues about a company's current priorities and future strategy. Let's take a look at the upcoming stock splits for the week. Jianzhi Education Technology Group (JZ) – Beijing‑based Jianzhi is a digital education provider offering online learning platforms and professional development content to higher education institutions and individuals across China. On June 12, the company announced an upcoming 1‑for‑10 reverse ADS split to boost its ADS trading price and maintain Nasdaq listing compliance. The split is scheduled to be effective at the start of trading on June 16. GlycoMimetics (GLYC) – U.S.-based GlycoMimetics is a clinical-stage biotech company developing treatments for sickle cell disease and cancer by targeting cell adhesion. On June 5, the company announced a 1-for-100 reverse stock split to support its planned merger with Crescent Biopharma. The split will take effect June 16, with shares trading under the new ticker CBIO as the combined company moves forward. Neo-Concept International Group Holdings (NCI) – Neo-Concept is a Hong Kong-headquartered apparel supplier and importer serving global e-commerce platforms. Following shareholder approval at its May 9 meeting, the company is rolling out a 1-for-5 reverse share consolidation. The adjustment takes place June 16. Shuttle Pharmaceuticals (SHPH) – Shuttle Pharmaceuticals is advancing a pipeline of radiation-sensitizing drugs aimed at improving cancer outcomes. On June 12, it unveiled a 1-for-25 reverse stock split to bring its share price back in line with Nasdaq's minimum bid requirement. The split becomes effective June 16, with SHPH shares trading on a split-adjusted basis that morning. Jeffs' Brands (JFBR) – Jeffs' Brands operates data-driven e-commerce brands across major online marketplaces, including Amazon. After securing shareholder approval, the company announced on June 12 a 1-for-17 reverse stock split aimed at maintaining its Nasdaq listing. The change goes live June 16. Security Matters (SMX) – Dublin-based Security Matters offers advanced digital tracking and authentication solutions for supply chains and product integrity. The company is implementing a 4.1-for-1 reverse stock split, which was approved earlier this spring and formally announced on June 12. The split is scheduled to take effect June 16. Glucotrack (GCTK) – Glucotrack is a med-tech innovator developing non-invasive glucose monitoring solutions for diabetes management. To meet Nasdaq compliance standards, the company announced a 1-for-60 reverse stock split on June 12, following prior shareholder approval at its May 22 annual meeting. The split becomes effective June 16. Regencell Bioscience Holdings (RGC) – Hong Kong–based Regencell is on a mission to treat neurocognitive disorders like ADHD and autism using traditional Chinese medicine. On June 2, the company unveiled a 38-for-1 forward stock split to boost liquidity and attract retail interest. Shareholders of record as of June 12 received their additional shares on June 13, and RGC began trading on a split-adjusted basis on June 16. Sensei Biotherapeutics (SNSE) – Sensei is a clinical-stage biotech based in Boston, developing next-gen immunotherapies to take on cancer. On June 13, the company announced a 1-for-20 reverse stock split in an effort to meet Nasdaq's minimum price threshold and maintain its listing. The split takes effect on June 16, with adjusted trading kicking off on June 17. RAPT Therapeutics (RAPT) – RAPT is advancing innovative therapies targeting inflammatory and autoimmune diseases. On June 13, the company rolled out a 1-for-8 reverse stock split aimed at reshaping its capital structure. The move becomes official on June 16, with split-adjusted shares starting to trade on June 17. FibroGen (FGEN) – FibroGen is a biotech company focused on fibrosis and other serious diseases. On June 12, it announced a 1-for-25 reverse stock split designed to help the stock climb back above the Nasdaq's minimum bid requirement. The split becomes effective on June 16, with trading on a split-adjusted basis beginning June 17. Interactive Brokers Group (IBKR) – A powerhouse in online trading, Interactive Brokers is known for serving active investors with low-cost, high-tech tools. On April 15, the company declared a 4-for-1 forward stock split to make shares more accessible to a broader investor base. Shareholders of record on June 16 received the extra shares on June 17, and IBKR stock began trading at the new price on June 18. TipRanks Stock Splits Calendar.
New York Post
2 hours ago
- New York Post
US Export-Import Bank considering $120M loan for Greenland rare earths project
Critical Metals Corp. has received a letter of interest from the U.S. Export-Import Bank for a loan worth up to $120 million to fund the company's Tanbreez rare earths mine in Greenland, in what would be the Trump administration's first overseas investment in a mining project. The loan, if approved, would boost U.S. access to minerals increasingly at the center of global economic trade and help offset the country's reliance on market leader China. It also comes after President Trump openly mused earlier this year about acquiring the Danish island territory, an overture that has been repeatedly rejected. In a letter dated June 12 and reviewed by Reuters, New York-based Critical Metals has met initial requirements to apply for the $120 million EXIM loan and, if approved, would have a 15-year repayment term, longer than the company likely would have with private financing. 4 A loan by the U.S. Export-Import Bank to fund Critical Minerals Corp.'s Tanbreez rare earths mine in Greenland would be the Trump administration's first overseas investment in a mining project. Getty Images The project would have to be 'well-capitalized with sufficient equity from strategic investors' to receive the loan, the letter said. EXIM, which acts as the U.S. government's export credit agency, said in the letter that Critical Metals qualifies for a loan program designed to support companies that compete with China. The Tanbreez project is expected to cost $290 million and the EXIM funds would be used to fund technical work and get the mine to initial production by 2026. Once fully operational, the mine is expected to produce 85,000 metric tons per year of a rare earths concentrate and two minor metals. 'This funding package is expected to unlock significant value for our project and our stakeholders,' said Tony Sage, the company's CEO. Representatives for EXIM were not immediately available to comment. The move is the latest in a series of supportive actions by Washington toward the Tanbreez deposit and Greenland's mining sector. Reuters reported in January the Biden administration had successfully lobbied privately held Tanbreez Mining not to sell to a Chinese developer and instead sell to Critical Metals. Biden officials were visiting Nuuk as recently as last November trying to woo additional private investment in the island. Trump sent Vice President JD Vance to the island in March. 4 Vice President JD Vance in Greenland in March. via REUTERS The island's mining sector has developed slowly in recent years, hindered by limited investor interest, bureaucratic challenges and environmental concerns. Currently, only two small mines are in operation. Rare earths have strong magnetic properties that make them critical to high-tech industries ranging from electric vehicles to missile systems. Their necessity has given rise to intense competition as Western countries try to lessen their dependence on China's near-total control of their extraction and processing. Beijing in April put export restrictions on rare earths as part of its trade spat with Trump. The two countries earlier this month reached a truce, although Beijing's control of the sector has exacerbated the West's over-reliance and sparked a global hunt for fresh supplies. 4 President Trump has openly mused about acquiring the Greenland from Denmark, which Copenhagen has rejected. REUTERS Despite the loan potential, Critical Metals would still have to either build a processing facility or find an existing site with spare capacity. The company told Reuters that its goal is to process the material inside the U.S., a goal the EXIM loan would make more achievable. Last year, Critical Metals had applied for funding to develop a processing facility from the U.S. Department of Defense, but the review process stalled ahead of Trump's January inauguration. 4 Greenland's mining sector has developed slowly in recent years, slowed by limited investor interest, bureaucratic challenges and environmental concerns. It has only two mines in operation. Getty Images For the EXIM loan's additional funding requirements, Critical Metals said it is considering offtake agreements, royalty streams and funding from other U.S. governmental agencies. Critical Metals told Reuters earlier this year that it has held supply talks with defense contractor Lockheed Martin, among others. Critical Metals' 10th-largest investor is brokerage firm Cantor Fitzgerald, which was formerly led by Howard Lutnick before he joined Trump's cabinet as commerce secretary. Sage told Reuters in January he had never met or talked to Lutnick, but acknowledged Cantor's investment was a positive for his company. EXIM last year extended a letter of interest to Perpetua Resources for a loan worth up to $1.8 billion for its antimony and gold mine in Idaho.
New York Post
3 hours ago
- New York Post
The growing case for rate cuts, federal cuts won't gut health care and other commentary
Fed watch: The Growing Case for Rate Cuts 'President Trump's tariffs present the Federal Reserve with two conflicting challenges,' observes The Wall Street Journal's Greg Ip. Tariffs 'raise prices, which weakens the case for cutting interest rates' but also 'sap confidence and demand, which strengthens the case.' So far, 'the Fed has focused on the first risk, keeping its interest rate target between 4.25% and 4.5% since December. It might soon have to pivot to the second': 'Evidence is accumulating that inflation, despite tariffs, has been milder than feared, while the labor market might be deteriorating.' Unemployment 'has risen every month since January, by a quarter percentage point in all.' A 'restrictive stance' on interest rates 'make sense so long as inflation is all the Fed has to worry about. It no longer is.' Eye on NY: Federal Cuts Won't Gut Health Care 'New York's health-care industry stands to lose billions of dollars in federal funding' under the GOP federal budget bill, notes the Empire Center's Bill Hammond, yet that wouldn't 'be enough to 'decimate' or 'gut' New York's health care system,' as Gov. Hochul has claimed. 'The House budget would reduce federal health-care aid by $10.1 billion while obliging the state to spend an additional $3.3 billion,' a state Health Department analysis finds — yet federal aid 'would still be higher than it was in 2023.' Cut the state's Medicaid enrollment by 1.2 million, and New York 'would still be providing free coverage to about 36 percent of its population' — still '12 points higher than the national average.' Republican: Don't Let Judges Help China Steal Tech The Patent Trial and Appeal Board is 'effectively allowing a Chinese firm to keep stealing an American semiconductor technology,' warns Rep. Nathaniel Moran at The Hill. The judges on the board 'just sided with Innoscience, a Chinese firm' accused of 'stealing patented technology and selling knockoff chips' from Cali company Efficient Power Conversion. 'After a 16-month investigation,' the US International Trade Commission 'found that Innoscience had indeed stolen the technology.' Yet Innoscience separately the patent board to invalidate Efficient Power Conversion's patent. 'The Trump administration has the authority to overrule' the board's 'dangerous decision' and 'should do so immediately,' but also 'implement broader reforms' to stop 'rogue administrative judges from helping Chinese companies pilfer US intellectual property in the future.' Democrats: San Francisco Shows the Way 'In the most famously liberal city in America, voters are no longer satisfied with symbolism or purity tests — they want results,' cheer Nancy Tung & Eric Kingsbury at Real Clear Politics. San Francisco voters 'still support Democratic principles, but they are demanding leaders who deliver.' In elections since 2022 through the rise of 'outsider' Mayor Daniel Lurie, voters are supporting a 'New Pragmatism' that's 'reshaping' how the Democratic Party 'governs and earns trust.' In other parts of the country, when 'voters asked for outcomes,' the party 'gave them process and vibes.' To win back voters, Dems 'need to be practical, not performative.' New Pragmatism is about 'solving problems, using power, and being honest about what is broken and what can be fixed.' If Democrats 'want to win again, they should start paying attention' to what voters want. Media watch: Don't Follow the Money? The media can 'no longer be trusted to tell anything like the truth,' blasts the Issues & Insights editorial board. 'The FBI is investigating the financial ties behind' the LA riots, but 'the mainstream press could care less,' fearing the facts might 'implicate Democrats or upset the left's agenda.' The Post has reported how the 'Party for Socialism and Liberation, which has ties to the Chinese Communist Party, is said to be behind some of the protests,' but other outlets remain mute. 'If you want to uncover corruption, find out where the money is coming from and where it is going. At least it used to be. Today? Not so much.' — Compiled by The Post Editorial Board
